1997
DOI: 10.1006/exnr.1997.6629
|View full text |Cite
|
Sign up to set email alerts
|

Insulin-like Growth Factor-1 (IGF-1) Improves both Neurological Motor and Cognitive Outcome Following Experimental Brain Injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
113
0
2

Year Published

2000
2000
2017
2017

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 173 publications
(124 citation statements)
references
References 68 publications
9
113
0
2
Order By: Relevance
“…Five animals died in the immediate post-injury period, producing an injury mortality of 18%, consistent with previous reports using the lateral FP brain injury model of moderate severity (Saatman et al, 1997).…”
Section: Resultssupporting
confidence: 90%
“…Five animals died in the immediate post-injury period, producing an injury mortality of 18%, consistent with previous reports using the lateral FP brain injury model of moderate severity (Saatman et al, 1997).…”
Section: Resultssupporting
confidence: 90%
“…It has been suggested that an increase in the expression of the IGF-I gene or peripherally administered IGF-I plays an important role in the neurotrophic response after injury such as epilepsy or ischemia in the adult rat brain (Gluckman et al, 1992;Guan et al, 1993;Breese et al, 1996;Saatman et al, 1997;Tagami et al, 1997;Liu et al, 1998;Hughes et al, 1999). Several disorders are associated with GCL pathology.…”
Section: Potential Of Induced Neurogenesis In the Dentate Gyrusmentioning
confidence: 99%
“…Experimental and clinical efforts aimed at treating this significant health care issue have resulted in numerous therapeutic approaches such as, but not limited to, anti-inflammatory and anti-oxidative strategies [4,34,36,39,51,56,101], hypothermia [5,9,13,14,21,57], and the exogenous administration of neurotrophins [19,84,88]. Another line of research that has received significant attention as a potential treatment strategy is the administration of various pharmacologic agents targeting both specific and non-specific neurotransmitter systems in an attempt to restore neural activity that has been altered by TBI [2,25,44,[51][52][53][54][55].…”
Section: Introductionmentioning
confidence: 99%